Clinical and epidemiological profile of chronic kidney disease patients in a tertiary care referral centre in South India

Swaraj Sathyan, Sunil George, Poornima Vijayan, Jayakumar M.


Background: The clinical course of CKD (chronic kidney disease) is typically a progressive loss of nephron function ultimately leading to end stage renal disease (ESRD) requiring some form of renal replacement therapy. As this puts a significant burden on global resources, planning for prevention of CKD by early identification of kidney damage by identifying and screening high-risk individuals is the most practical solution. Aim: To study the clinico-epidemiological profile of newly diagnosed cases of CKD.

Methods: This study was conducted between January 2008 and June 2008 at a Government tertiary referral institution in South India. All newly diagnosed cases of CKD based on the National Kidney foundation definition  were included in this study.

Results: Of the total 333 patients included in the study, 217 (65%) were males and 116 (35%) were females. Majority (275, 82.59%) of the patients were between 21-60 years of age. Chronic glomerulonephritis was by far the most common etiological diagnosis (51%) followed by diabetic nephropathy (22%) and hypertensive nephrosclerosis (7%) . About 24% had diabetes mellitus while 84% of the patients had hypertension. Dyspnea (75.68%), symptoms suggestive of volume overload in 242 (72.7%) and Oliguria (69%) were the chief presenting complaint. An overwhelming majority of the patients in the study presented in stage 5 CKD (264, 79.2%). 167 (50.15%) patients were found to have some form of cardiovascular disease. Cigarette smoking was prevalent in 32.7%, alcohol consumption in 6.91%, NSAID use in 5.1% and herbominerals in 4.5% .The mean hemoglobin in the study was 8.42 g/dl. Mean phosphate level in the study was 5.94 mg/dl. There was significant statistical correlation between hemoglobin level and stage of CKD and also between serum phosphate level and stage of CKD.

Conclusions: Early detection of CKD by screening of high risk individuals will go a long way in retarding the progression of ESRD. This will help in bringing down the huge burden due to mismatch between demand and availability of resources for renal replacement therapy in developing countries like India, especially for patients belonging to lower socioeconomic group.


CKD, Clinical profile, Epidemiological profile, ESRD, Etiology of CKD, Risk factors

Full Text:



National Kidney foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation,classification and stratification. AM J Kidney Dis. 2002;39(2suppl1):S18.

Mani MK. Prevention of chronic renal failure at the community level. Kidney International. 2003;63:586-9.

Levey AS, Greene T, Kusek J, Beck GL; MDRD Study Group. Simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11:155A.

Silbiger SR, Neugarten J. The impact of gender on the progression of chronic renal disease. Am J Kidney Dis. 1995;25:515-53.

Khalil RA. Sex hormones as potential modulators of vascular function in hypertension. Hypertension. 2005;46:249-54.

Rajapurkar MM. 2nd annual report, CKD registry of India, Proceedings of the 38th annual conference of Indian society of Nephrology, 13-15 Dec, 2007, Delhi.

Dharan KS, John GT, Neelakantan N. Spectrum of severe chronic kidney disease in India: A clinicopathological study. Natl Med J India. 2006;19:250-2.

Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc. 1985;33:278-85.

Gee GC, Payne-Struges DC. Environmental health disparities: A framework integrating psychosocial and environmental concepts. Environ Health Perspect. 2004;112:1645-53.

Volkova N, McClellan W, Klein M. Neighbourhood poverty and racial differences in ESRD incidence. J Am Soc Nephrol. 2008;19:356-64.

Foley RN, Parfrey PS. Cardiac disease in chronic uremia: clinical outcomes and risk factors. Adv Ren Replace Ther. 1997;4:234-8.

Levey AS, Beto JA, Coronado BE. National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis. 1998;32:853-906.